THERAPY BY MS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
THERAPY BY MS
Largest movements
- Cash -€7,521
down €7,521 (-56.0%), from €13,440 to €5,919
mainly Net result for the year (-€13,116) and Investment in fixed assets (net) (-€2,190)
- Deferred charges and accrued income +€1,800
new in 2025: €1,800
- Tangible fixed assets +€829
up €829 (+52.4%), from €1,582 to €2,411
- Profit (loss) carried forward -€13,116
down €13,116 (-2775.3%), from -€473 to -€13,589
- Trade debts +€4,590
up €4,590 (+126.1%), from €3,641 to €8,231
- Other debts +€2,834
up €2,834 (+30.4%), from €9,330 to €12,164
- Tax, wage and social debts +€799
up €799 (+52.4%), from €1,524 to €2,323
of which Remuneration and social security: +€799
- Gross operating margin -€21,868
down €21,868, from €13,532 to -€8,336
- Staff costs -€3,949
down €3,949 (-82.0%), from €4,813 to €864
- Taxes -€1,524
no longer reported in 2025 (was €1,524)
- Other operating charges -€1,108
down €1,108 (-30.9%), from €3,587 to €2,480
- Depreciation +€752
up €752 (+123.4%), from €609 to €1,361
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €15,022 | €10,130 | -€4,892 | -32.6% |
| Fixed assets | 21/28 | €1,582 | €2,411 | +€829 | +52.4% |
| Tangible fixed assets | 22/27 | €1,582 | €2,411 | +€829 | +52.4% |
| Furniture and vehicles | 24 | €1,582 | €2,411 | +€829 | +52.4% |
| Current assets | 29/58 | €13,440 | €7,719 | -€5,721 | -42.6% |
| Cash at bank and in hand | 54/58 | €13,440 | €5,919 | -€7,521 | -56.0% |
| Deferred charges and accrued income | 490/1 | - | €1,800 | +€1,800 | |
| Total equity and liabilities | 10/49 | €15,022 | €10,130 | -€4,892 | -32.6% |
| Equity | 10/15 | €527 | -€12,589 | -€13,116 | |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€473 | -€13,589 | -€13,116 | -2775.3% |
| Amounts payable | 17/49 | €14,495 | €22,719 | +€8,224 | +56.7% |
| Amounts payable within one year | 42/48 | €14,495 | €22,719 | +€8,224 | +56.7% |
| Trade debts | 44 | €3,641 | €8,231 | +€4,590 | +126.1% |
| Suppliers | 440/4 | €3,641 | €8,231 | +€4,590 | +126.1% |
| Taxes, remuneration and social security | 45 | €1,524 | €2,323 | +€799 | +52.4% |
| Taxes | 450/3 | €1,524 | €1,524 | = | 0.0% |
| Remuneration and social security | 454/9 | - | €799 | +€799 | |
| Other amounts payable | 47/48 | €9,330 | €12,164 | +€2,834 | +30.4% |
| Remuneration, social security and pensions | 62 | €4,813 | €864 | -€3,949 | -82.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €609 | €1,361 | +€752 | +123.4% |
| Other operating charges | 640/8 | €3,587 | €2,480 | -€1,108 | -30.9% |
| Gross operating margin | 9900 | €13,532 | -€8,336 | -€21,868 | |
| Operating profit (loss) | 9901 | €4,521 | -€13,041 | -€17,563 | |
| Financial charges | 65/66B | €71 | €75 | +€4 | +5.7% |
| Recurring financial charges | 65 | €71 | €75 | +€4 | +5.7% |
| Profit (loss) for the period before taxes | 9903 | €4,451 | -€13,116 | -€17,567 | |
| Income taxes | 67/77 | €1,524 | - | -€1,524 | |
| Profit (loss) for the period | 9904 | €2,927 | -€13,116 | -€16,043 | |
| Profit (loss) for the period to be appropriated | 9905 | €2,927 | -€13,116 | -€16,043 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.